Section R4-19-512. Prescribing Drugs and Devices

A.      An RNP granted P & D authority by the Board may:

1.        Prescribe drugs and devices;

2.        Provide for refill of prescription-only drugs and devices for one year from the date of the prescription.

B.       An RNP with P & D authority who wishes to prescribe a con- trolled substance shall obtain a DEA registration number before prescribing a controlled substance. The RNP shall file the DEA registration number with the Board.

C.      An RNP with a DEA registration number may prescribe:

1.        A Schedule II controlled substance as defined in the fed- eral Controlled Substances Act, 21 U.S.C. § 801 et seq., or Arizona's Uniform Controlled Substances Act, A.R.S. Title 36, Chapter 27, but shall not prescribe refills of the prescription;

2.        A Schedule III or IV controlled substance, as defined in the federal Controlled Substances Act or Arizona's Uni- form Controlled Substances Act, and may prescribe a maximum of five refills in six months; and

3.        A Schedule V controlled substance, as defined in the fed- eral Controlled Substances Act or Arizona's Uniform Controlled Substances Act, and may prescribe refills for a maximum of one year.

D.      An RNP whose DEA registration is revoked or expires shall not prescribe controlled substances. An RNP whose DEA reg- istration is revoked or limited shall report the action to the Board.

E.       In all outpatient settings or at the time of hospital discharge, an RNP with P & D authority shall personally provide a patient or the patient's representative with the name of the drug, direc- tions for use, and any special instructions, precautions, or stor- age requirements necessary for safe and effective use of the drug if any of the following occurs:

1.        A new drug is prescribed or there is a change in the dose, form, or direction for use in a previously prescribed drug;

2.        In the RNP's professional judgment, these instructions are warranted; or

3.        The patient or patient's representative requests instruc- tion.

F.       An RNP with P & D authority shall ensure that all prescription orders contain the following:

1.        The RNP's name, address, telephone number, and popula- tion focus;

2.        The prescription date;

3.        The name of the patient and either the address of the patient or a blank for the address if the prescription is not being dispensed by the RNP;

4.        The full name of the drug, strength, dosage form, and directions for use;

5.        The letters “DAW”, “dispense as written”, “do not substi- tute”, “medically necessary” or any similar statement on the face of the prescription form if intending to prevent substitution of the drug;

6.        The RNP's DEA registration number, if applicable; and

7.        The RNP's signature.

Historical Note

Former R4-19-512 renumbered to R4-19-514; new R4- 19-512 made by final rulemaking at 11 A.A.R. 3804,

effective November 12, 2005 (05-3). Amended by final

rulemaking at 19 A.A.R. 1438, effective July 6, 2013

(Supp. 13-2).